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The metabolism of PHlvitamin D~ was studied in euhured Iluman keratinocytes (CHK). Intact CHK were incubated for I, 6, 12, 24 and 48 h 
with [aHlvitamin D:~ and the lipid soluble, fractions from the media =tnd cells were extracted by high.l~rformane¢: li~luid chromatography ([IPLC), 
Vitamin D= and its metabolism. 2$.OH.D~, 24,25(OH)aD = and 1,25(OH)= D~ were added to the extracts, as markers, prior to HPLC. HPLC analysis 
of the lipid extracts did not reveal any monohydroxylated metaboli|es, CEll(. incubated for one hour with pH]2S.OH.Dj showed a 10:1:4~, con. 
version to pH]I,2$(OH)=D a whereas no conversion to pH]l,25(OH)aD ~ was observed in control CHKs that were boiled prior to incubation with 
pH]2~-OH-D=. These findings uggest hat cultured neonatal keratinocytes are ;neap.bit of metabolixinl¢ vilamin D~ to 25-OH-Dp 
Cultured human keratinocyte; Vitamin D~ 25-Hydroxyvitamin D~ 
1, INTRODUCTION 
When human skin is exposed to sunlight, vitamin D3 
is produced [1]. Once formed, vitamin D3 is transported 
via a vitamin D-binding protein to the liver where it is 
metabolized to 25-OH-D3 which is further metabolized 
in the kidney to 1,25(OH)2Dj, the most biologically ac- 
tive form of vitamin Da [2], 
Receptors for 1,25(OH)2D3 have been demonstrated 
in cultured human and mouse keratinocytes [3,4] and in 
cultured human dermal fibroblasts (CHDF) [3, 5, 6]. In- 
cubation of both cultured human keratinocytes [CHK] 
and CI-IDF with 1,25(OH)zD3 caused a dose-dependent 
decrease in cell proliferation and in CHK, an increase m 
differentiation [7]. 
Cultured neonatal keratinocytes metabolize 25-OH- 
D~ to 1,25(OH)2D3 [8], Since the skin is the site for 
vitamin D3 synthesis and a target organ for its 1,25- 
dihydroxy metabolite, it was of interest o determine 
whether CHK could also metabolize vitamin D3 to 
25-OH-Dj, 
2, METHODS AND MATERIALS 
2,1, Cultured human keratinocytes 
Cultured human keratinocytes were grown in serum.free conditions 
as previously described [7]. Briefly, the medium consisted o f  
Dulbecco's modified Eagle's medium (DMEM) with 0.15 mM calcium 
(M,A, Bioproducts, Walersville, MD, USA) containing 7 growth fac- 
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tors: tr~nsferrin (5 ~q~/ml), epidermal growth factor (25 ng/ml), 
hydrocortison¢ (203 mg/ml), insulin (5 gg/ml), prostaglandln E-I 
(50 ng/ml), cholera toxin (O,t pg/ml. Sigma, St, Louis, MO, USA), 
and selenous acid (2 ng/ml, Collaborative Research, Lexington, MA, 
USA), Penicillin G (TS U/ml) and streptomycin (SO nglnd) were also 
added to the cultures. Keratinocytes were isolated from human neo. 
natal foreskin according to a modi fication of the method of Rheinwald 
and Green [91. For the experiments studied, fresh medium containing 
vehicle alone (0,01% ethanol) or one of the following compounds 
1,25(OH)_.D.~, 24,25(OH)zD~ (gifts from Dr. M, Uskokovic of 
Hoffmann.La Roche; Nutley, New Yerseyl, 25.OH-D3 (a gift f~om 
J, Babcock of Up john, Kalamazoo, Michigan) or vitamin D3 (Sigma, 
St, Louis, MO) was added to each culture, Radioactive vitamin D3 
was from Amersham, TR.K 346, Batch 33, [lot,2ct-ZHlvitamin-Dj, 
18,3 Ci/mmol, 
2.2, incubation of cultured human keratinocytes with [JH]vitamin D3 
Triplicate 35 mm cultures of CHK that were approximately 80°70 
confluent were incubated with 100000 cpm of [JHlvitamin D3 for l, 
6, 120 24, or 48 h. The medium was collected and the cells washed 2 
times with medium which was combit~ed with the first. Lipid extracts 
were obtained separately from the cells and the medium by adding 7 
ml of methanol and 5 ml of  H20 and then transferring the mixture to 
a separati,-g flasK. Methylene chloride C4 ml) was added to the flask 
until a precipitate formed, and then an additional 16 ml was added, 
After mixing, the lipid-soluble (bottom) layer was removed and dried 
with nitrogen. To this, 20% IPA/hexane was added and the mixture 
was dried down with nitrogen Cold standards were added to the ex- 
tract (16 ng/ml of 1,25(OH)2Dj, 35 ng/ml of 25-OH-D~, 1 ng/ml of 
vitamin D3 and 20 ng/ml 24,25(OH)2Dj) prior to analysis by HPLC. 
Samples were elated at a flow rate of 2.5 ml/min with a step-gradient 
of lsopropanol in n.hexane on a 25 x 4.5 mm Zorbx-sil column as 
follows; 1 25°7o from 0 to 15 rain; 2,5% from 16 to 35 rain, and 5% 
from 36 to 70 ;~nin, The various Standards were monitored by their UV 
absorbance at 254 rim, One ml fractions were collected and counted 
~n a liquid scintillation counter. This system was used to separate the 
vitamin Dj, 25-OH-D3, 24,25(OH)2D~ and t,25(OH)2D~. For the 
study of the conversion of 25-OH-D3 to 1,25(OH)2D3, the step- 
gradient of isopropanol in n.hexane was changed to 2.5°7o for 0 to 40 
rain and5% for 41 to  70 rain and the flow rate was 2,0 ml/min. 
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3, RESULTS 
To be certain that [~H]vitamtn D~ entered the kera. 
tinocytes, the cells were incubated with [~Hlvitamin D~ 
and then at various times the cells and medium were 
harvested. At 1, 12 and 24 hatter its addition, 28 ± 5=/0, 
ts0 ~: 9% and 61 ¢ 6~o, respectively, of the [~H]vitamln 
D~ entered the cells and was available to intracellular 
enzymes. Accumulation of [~H]vhamin D~ peaked at 
24 h with no siinificant difference from 24 (61 a: 6~) to 
48 h (66±8%), P>O.0$. At all times tested, RR .~6% of 
the radioactivity was recovered from both the ~ells and 
the medium as [~Hlvitamin D~, The other 12¢ 4% was 
recovered in the water soluble phase of the extraction, 
A comparison of HPLC chromato~rams of the stan- 
dards (FIB. IA) with the lipid extracts of cells (Fig, 
i B, C!:tand medium (Fie, ID, E) foliowinll incubation 
with | H]vitamin D~ rot ! h (Fill. IB, D) and 12 h (Fill, 
IC, E] demonstrated that there ~as no metabolism of 
vitamin D~ to known mono- and di-hydroxylated meta- 
boiites. Similar results were obtained from both cells 
and medium for the ItS mln, 6 and 48 h incubations 
(data not shown). To be certain that the CHK retained 
the capacity to metabolize 25-OH.D:h CHK were in. 
cubated, in triplicate, with [~H]25.OH.D~ for I I~, As 
seen i:n FiB, 2A, I0% of  the [ )'H]2ts-OH.D:~ converted to 
["H] 1,2~(OH)=D), The overall conversion tor the tripli. 
cate samples was 10¢4%, The [:!H]I,25(OH)~D:~ peak 
was collected and shown to miscrate with 1,2ts(OH)aD~ 
standard (data not shown), CHKs that :were boiled 
prior to incubation with [~H]25-OH-D~, demonstrated 
no conversion to [~H]I,25(OH)aD~ (Fill. 2B). 
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Fig, 1, Representative chromatograms from standards (A, 1, vitamin 
D3; 2, 25-OH-D3; 3, 24,25(OH)2D3; 4, 1,25(OH)2D3) and cultured 
human keratinocytes (B,C) and the incubation medium (D,E) after 
incubation with [3H]vitamin D3 (100000 cpm) for 1 (B,D) and 12 h 
(C, E), The cells and the medium were kept separate and the lipid frac- 
tions wereextracted and separated on HPLC (see section 2). 1 ml frac- 
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Fig, 2. Lipid extracts of cultured human keratinocytes (A) after 1 h 
incubation with [3H]25.OH.D~ at 3/°C and analyzed by HPLC (see 
section 2). 1 ml fractions were collected and counted in a scintillation 
counter. The tritiated polar metabolite peal~ (rt = 6i mix) co-eluted 
with standard 1,25(OH)2D ~. Fig. 2B is an HPLC chromatogram of
the lipid extract of keratinocytes that have been boiled prior to in- 
cubation with [3H]25-OH..D3, There was no conversion of the 
[3H]25..OH-D3 to 13H] 1,25(OH)2D 3. 
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4, DISCUSSION REFERENCES 
InvestiBators have shown that CHKs [31 possess 
nuclear receptors for 1,25(OH)iDj and that human 
skin may be li iarliet tlslue rot 1,25(OH)~Dj [6,7], 
CHK metabolize iS .OH.D)  to both i ,2$(OH)iD) and 
24.25(OH)=D~ 17,81. 
It h i s  previously been shown [10] that hcpatectomlz- 
ed, vitamin-D-deficient rats that received vitamin D=, 
maintained low. but detectable levels of 25.OH-D~. 
This suuests that the liver was not the sole site for the 
metabolism of vitamin D~ to 25-OH-D~. Our restllts 
demonstrate that CHK, which convert 25-OH-Ds to 
1,25(OHhD3, cannot metabolize vitamin Ds to 25-OH- 
D3, These results su l lest  that the human epidermis is 
unable to metabolize sunlight induced vitamin D~ to 
i ,25(OH)iD). 
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